UnitedHealth (UNH) Stock Rated Outperform Despite Lowered Price Target by Leerink

UnitedHealth Group Incorporated (NYSE:UNH) ranks among the best low volatility stocks to buy according to analysts. On July 15, Leerink Partners maintained its Outperform rating on UnitedHealth Group Incorporated (NYSE:UNH) but lowered its price target from $355 to $340. The firm noted that as the market awaits UnitedHealth to reinstate its 2025 financial forecast, investor expectations have been “moderately fading” over the past month.

According to Leerink Partners, the market typically anticipates earnings between $18 and $19 per share, so guidance in this range should allay worries due to the “materiality of the reduction in overall margins.”

Such a forecast, according to the analyst report, would lay the foundation for a “multi-year margin story,” with growth possibly picking up speed in 2027 as UnitedHealth Group Incorporated (NYSE:UNH) departs V28.

UnitedHealth Group Incorporated (NYSE:UNH) is a renowned US multinational corporation that provides managed healthcare and insurance services. The company operates through four main segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx.

While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

Read More: 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds

Disclosure: None.